01 1Alchymars ICM SM Private Limited
02 1Apotex Inc.
03 1Aurobindo Pharma Limited
04 1Cipla Ltd.
05 1Hetero Drugs Limited
06 1Jubilant Biosys limited
07 1SUN PHARMACEUTICAL INDUSTRIES, INC.
08 1Synthimed Labs Private Limited
09 1TAPI Croatia Industries Ltd.
01 1RISEDRONATE SODIUM HEMIPENTAHYDRATE
02 7Risedronate Sodium
03 1Risedronate Sodium Hemipentahydrate
01 1Canada
02 1Croatia
03 7India
NDC Package Code : 14998-0008
Start Marketing Date : 2010-09-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
RISEDRONATE SODIUM HEMI-PENTAHYDRATE
NDC Package Code : 49867-0068
Start Marketing Date : 2017-12-29
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
RISEDRONATE SODIUM HEMI-PENTAHYDRATE
NDC Package Code : 65862-396
Start Marketing Date : 2024-01-10
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7653
Start Marketing Date : 2016-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0092
Start Marketing Date : 2010-10-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65372-1113
Start Marketing Date : 2006-11-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 11722-077
Start Marketing Date : 2021-07-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62756-255
Start Marketing Date : 2025-03-31
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65096-0110
Start Marketing Date : 2010-11-01
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
24
PharmaCompass offers a list of Risedronate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Risedronate Sodium manufacturer or Risedronate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Risedronate Sodium manufacturer or Risedronate Sodium supplier.
A Risedronic Acid manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Risedronic Acid, including repackagers and relabelers. The FDA regulates Risedronic Acid manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Risedronic Acid API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Risedronic Acid manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Risedronic Acid supplier is an individual or a company that provides Risedronic Acid active pharmaceutical ingredient (API) or Risedronic Acid finished formulations upon request. The Risedronic Acid suppliers may include Risedronic Acid API manufacturers, exporters, distributors and traders.
click here to find a list of Risedronic Acid suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Risedronic Acid as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Risedronic Acid API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Risedronic Acid as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Risedronic Acid and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Risedronic Acid NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Risedronic Acid suppliers with NDC on PharmaCompass.
We have 9 companies offering Risedronic Acid
Get in contact with the supplier of your choice:
